Amrize Forecast, price target & analysts
Amrize Target price 2026 - Analyst rating & recommendation
Amrize Classifications & Recommendation
Amrize Price Target
| Target Price | $56.10 |
| Price | $38.19 |
| Potential | 46.90% |
| Number of Estimates | 23 |
| 23 Analysts have issued a price target Amrize 2027 . The average Amrize target price is $56.10. This is 46.90% higher than the current stock price. The highest price target is $73.50 92.46% , the lowest is $48.48 26.94% . | |
| A rating was issued by 28 analysts: 18 Analysts recommend Amrize to buy, 9 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Amrize stock has an average upside potential 2027 of 46.90% . Most analysts recommend the Amrize stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
25 Analysts have issued a sales forecast Amrize 2026 . The average Amrize sales estimate is
This results in the following potential growth metrics:
24 Analysts have issued an Amrize EBITDA forecast 2026. The average Amrize EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Amrize Analysts have issued a net profit forecast 2026. The average Amrize net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
24 Analysts have issued a Amrize forecast for earnings per share. The average Amrize EPS is
This results in the following potential growth metrics and future valuations:
Current Amrize Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Overweight
➜
Equal-Weight
|
Downgrade | Sep 09 2026 |
| B of A Securities |
Neutral
➜
Underperform
|
Downgrade | Sep 02 2026 |
| JP Morgan |
Overweight
➜
Neutral
|
Downgrade | Sep 02 2026 |
| DA Davidson |
➜
Neutral
|
Initiated | Aug 25 2026 |
| Stephens & Co. |
Overweight
➜
Overweight
|
Unchanged | Aug 12 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Aug 11 2026 |
| RBC Capital |
Sector Perform
➜
Underperform
|
Downgrade | Aug 10 2026 |
| Analyst Rating | Date |
|---|---|
|
Downgrade
Wells Fargo:
Overweight
➜
Equal-Weight
|
Sep 09 2026 |
|
Downgrade
B of A Securities:
Neutral
➜
Underperform
|
Sep 02 2026 |
|
Downgrade
JP Morgan:
Overweight
➜
Neutral
|
Sep 02 2026 |
|
Initiated
DA Davidson:
➜
Neutral
|
Aug 25 2026 |
|
Unchanged
Stephens & Co.:
Overweight
➜
Overweight
|
Aug 12 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Aug 11 2026 |
|
Downgrade
RBC Capital:
Sector Perform
➜
Underperform
|
Aug 10 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
